Blau Farmaceutica SA (BLAU3) Stock Price & News

BLAU3:BVMF

Blau Farmaceutica SA

R$9.78

0.00%

(0.00) 1D

Nov 13, 6:04:00 PM GMT-3 · BRL

All symbols

	Symbol	Price	Change	% Change

Last report

Nov 11, 2026

Fiscal period

Q3 2026

R$0.30 / R$0.32

-5.94%miss

Revenue / Est. (BRL)

506.34M / 514.52M

-1.59%miss

Fiscal Q3 2026 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in BRL

Loading Previous Earnings...

All values in BRL	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	475.20M	389.36M	434.97M	486.60M
Cost of goods sold	282.46M	235.99M	254.72M	274.60M
Cost of revenue	282.46M	235.99M	254.72M	274.60M
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	90.17M	100.07M	94.55M	100.58M
Operating expense	101.15M	104.83M	95.01M	128.66M
Total operating expenses	383.61M	340.82M	349.73M	403.25M
Operating income	91.59M	48.54M	85.24M	83.34M
Other non operating income	-	-2.58M	-2.87M	-
EBT including unusual items	138.33M	44.19M	52.20M	65.45M
EBT excluding unusual items	138.33M	44.19M	52.20M	65.45M
Income tax expense	32.81M	6.81M	15.92M	9.91M
Effective tax rate	23.72%	15.41%	30.49%	15.15%
Other operating expenses	10.98M	4.76M	461.00K	28.08M
Net income	104.42M	36.25M	39.77M	53.39M
Net profit margin	21.97%	9.31%	9.14%	10.97%
Earnings per share	0.53	-	0.17	0.31
Interest and investment income	106.52M	9.95M	12.94M	18.65M
Interest expense	-59.77M	-22.99M	-21.35M	-36.54M
Net interest expenses	46.75M	-13.04M	-8.41M	-17.89M
Depreciation and amortization charges	-	-	-	-
EBITDA	103.32M	62.47M	99.62M	98.53M
Gain or loss from assets sale	-	50.02M	-	-

Finance